NCT05119855 · Interventional trial
Safety and Immunogenicity of 9-valent Human Papillomavirus (9vHPV) Vaccine Coadministered With Messenger Ribonucleic Acid (mRNA)-1273 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) (COVID-19) Vaccine (V503-076)
Overall registry status Completed
Phase 3
Conditions Coronavirus Disease (COVID-19), Papillomavirus Infections
Delaware Valley sites
- Thomas Jefferson University - Family and Community Medicine ( Site 0006) · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory